Mianserin.
D000380:Agranulocytosis / Q000139:chemically induced*; D004363:Drug Utilization; D006801:Humans; D008803:Mianserin / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing; D014342:Truth Disclosure
D008803:Mianserin